Is a complete HCWB research report available?

No complete published report is available for HCW Biologics Inc. (HCWB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

HCW Biologics Inc. (HCWB)

NASDAQ: HCWB · USD

$3.15

+0.57 (+22.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first HCWB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	3.8M
Revenue (ttm)	6.6M
Net income (ttm)	-18.1M
EPS (ttm)	-$34.2
Shares out	1.2M
Volume	95,258
Beta	2.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.6M
Net income (ttm): -18.1M
EPS (ttm): -$34.2
Market cap: 3.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All HCWB indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001828673
Company name	HCW Biologics Inc.
Country	United States
Country code	US
Cusip	40423R303
Employees	35
Employees Change	-1%
Employees Change Percent	-2.78
Enterprise value	$9.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-20
Isin	US40423R3030
Last refreshed	2026-07-31
Market cap	$3.8M
Market cap category	Nano-Cap
Price	$3.15
Price currency	USD
Rev Per Employee	188,347.66x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	HCWB
Website	https://www.hcwbiologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-481.91%
EV/Sales	1.38x
FCF yield	-304.63%
P/B ratio	0.61x
P/S ratio	0.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-121.09%
EBITDA Margin	-109.49%
Gross margin	99.24%
Gross Profit	$6.5M
Gross Profit Growth	1,792.49%
Gross Profit Growth Q	644,710.46%
Gross Profit Growth3 Y	100.68%
Gross Profit Growth5 Y	9.8%
Net Income	$-18.1M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-29.73%
Profit Margin	-34.74%
Profit Per Employee	$-517,652
Profitable Quarters	$1
ROA	-15.06
Roa5y	-35.36
ROCE	-108.1
ROIC	-45.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-88.11%
Cagr3y	-81.48%
Cagr5y	-69.55%
EPS Growth Quarters	7
EPS Growth Years	1
Revenue Growth	356.16x
Revenue Growth Q	129,080.67x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	21.82x
Revenue Growth5 Y	9.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.25
Assets	$27.3M
Cash	$1.2M
Current Assets	$1.7M
Current Liabilities	$20M
Debt	$6.6M
Debt Equity	$1.14
Equity	$5.8M
Interest Coverage	-11.43
Liabilities	$21.6M
Long Term Assets	$25.6M
Long Term Liabilities	$1.6M
Net Cash	$-5.3M
Net Cash By Market Cap	$-142
Net Debt Equity	$0.93
Tangible Book Value	$5.8M
Tangible Book Value Per Share	$5.13
WACC	11.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.09
Net Working Capital	$-12.9M
Quick ratio	0.07
Working Capital	$-18.2M
Working Capital Turnover	$-0.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-212.37%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-88.1%
200-day SMA	8.18
3Y total return	-99.37%
50-day SMA	6.95
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.74%
All Time High	1,866
All Time High Change	-99.83%
All Time High Date	2021-07-20
All Time Low	1.5
All Time Low Change	110%
All Time Low Date	2026-04-02
ATR	0.63
Beta	2.3
Beta1y	2.32
Beta2y	1.35
Ch YTD	-45.91
High	3.32
High52	44.1
High52 Date	2025-08-25
High52ch	-92.86%
Low	2.52
Low52	1.5
Low52 Date	2026-04-02
Low52ch	110%
Ma50ch	-54.65%
Premarket Change Percent	-2.25
Premarket Price	$2.52
Premarket Volume	894
Price vs 200-day SMA	-61.47%
RSI	36.35
RSI Monthly	29.34
RSI Weekly	40.87
Sharpe ratio	0.29x
Sortino ratio	1
Total Return	-212.37%
Tr YTD	-45.91
Tr1m	-40.07%
Tr1w	9.38%
Tr3m	28.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-1.98
Operating Income	$-6.5M
Operating margin	-98.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,036,915%
Float Percent	86.88%
Net Borrowing	-204,466
Shares Insiders	13.12%
Shares Institutions	11.36%
Shares Out	1,193,524
Shares Qo Q	60.34%
Shares Yo Y	212.37%
Short Float	2.89%
Short Ratio	0.24
Short Shares	2.51

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-12M
Adjusted OCF	-11,955,987
Average Volume	58,091.6x
Bv Per Share	5.13
Ch1m	-40.07
Ch1w	9.38
Ch1y	-88.1
Ch3m	28.83
Ch3y	-99.37
Ch5y	-99.74
Ch6m	-53.95
Change	22.09%
Change From Open	23.53
Close	2.58
Days Gap	-1.16
Depreciation Amortization	764,810
Dollar Volume	300,062.7
Earnings Date	2026-08-17
Earnings Time	bmo
EBIT	$-8M
EBITDA	$-7.2M
EPS	$-34.24
F Score	4
FCF	$-11.5M
FCF EV Yield	-125.75x
FCF Per Share	$-9.6
Financing CF	11,574,253
Fiscal Year End	December
Founded	2,018
Income Tax	$330,186
Ipr	-60.63
Iprfo	-99.83
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2026-06-30
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	5.29
Ma150ch	-40.45%
Ma20	3.76
Ma20ch	-16.22%
Net CF	121,266
Next Earnings Date	2026-08-17
Open	2.55
Optionable	No
Position In Range	78.85
Post Close	3.15
Postmarket Change Percent	-5.71
Postmarket Price	$2.97
Ppne	20,766,082
Pre Close	2.58
Price Date	2026-07-30
Ptbv Ratio	0.65
Relative Volume	1.64x
Revenue	6,592,168x
SBC By Revenue	7.63x
Share Based Comp	503,000
Tax By Revenue	5.01x
Tr6m	-53.95%
Us State	Florida
Volume	95,258
Z Score	-6.52

HCW Biologics Inc. (HCWB)

Coverage state: Market snapshot only — no published research

Generate the first HCWB analysis

Price

Financial snapshot

Fair-value bridge

Latest news · HCWB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HCWB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on HCWB

Frequently asked questions